259 related articles for article (PubMed ID: 8589295)
1. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
[TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
Honda K; Hara M; Ogura Y; Nihei H; Mimura N
Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural evidence for colocalization of kappa light chain- and beta 2-microglobulin-derived amyloids using double labelling immunogold electron microscopy.
Takahashi M; Hoshii Y; Kawano H; Gondo T; Ishihara T; Isobe T
Virchows Arch; 1996 Dec; 429(6):383-8. PubMed ID: 8982384
[TBL] [Abstract][Full Text] [Related]
4. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
5. Related bindings of aggregated beta 2-microglobulin, IgG Fab, kappa and lambda light chains to group A streptococci.
Persson MH; Schalén C; Berggård B; Lögdberg L; Björck L
Acta Pathol Microbiol Immunol Scand B; 1986 Feb; 94(1):25-31. PubMed ID: 3088909
[TBL] [Abstract][Full Text] [Related]
6. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of beta2 microglobulin and lambda light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis.
Fujimoto N; Wada N; Akiyama M; Tajima S; Ishibashi A; Miyakawa S
Br J Dermatol; 2002 Sep; 147(3):549-53. PubMed ID: 12207599
[TBL] [Abstract][Full Text] [Related]
8. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
9. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient].
Menet E; Petit ML; Bridoux F; Touchard G; Duport G; Levillain P; Babin P
Nephrologie; 2001; 22(3):115-8. PubMed ID: 11436666
[TBL] [Abstract][Full Text] [Related]
10. Roles of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis.
Ito K; Hashimoto K; Kambe N; Van S
J Invest Dermatol; 1987 Oct; 89(4):415-8. PubMed ID: 3117902
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
13. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
14. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
Gouin-Charnet A; Mourad G; Argilés A
Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
[TBL] [Abstract][Full Text] [Related]
16. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis].
Mikhaleva LM; Gioeva ZV; Rёken K
Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775
[TBL] [Abstract][Full Text] [Related]
17. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
20. Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis.
Campistol JM; Bernard D; Papastoitsis G; Solé M; Kasirsky J; Skinner M
Kidney Int; 1996 Oct; 50(4):1262-7. PubMed ID: 8887286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
